{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:17:09Z","timestamp":1790705829308,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/ico.0b013e31823f8cb6","type":"journal-article","created":{"date-parts":[[2012,6,17]],"date-time":"2012-06-17T22:10:23Z","timestamp":1339971023000},"page":"994-999","source":"Crossref","is-referenced-by-count":76,"title":["Tear Film Osmolarity in Patients Treated for Glaucoma or Ocular Hypertension"],"prefix":"10.1097","volume":"31","author":[{"given":"Antoine","family":"Labb\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lie","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Brasnu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Van Went","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1542-0124(12)70120-9","article-title":"Effects of topical antiglaucoma medications on the ocular surface.","volume":"3","author":"Asbell","year":"2005","journal-title":"Ocul Surf"},{"key":"R2-6-20210204","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":". Preservatives in eyedrops: the good, the bad and the ugly.","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"R3-6-20210204","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","article-title":". Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.","volume":"29","author":"Fechtner","year":"2010","journal-title":"Cornea"},{"key":"R4-6-20210204","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","article-title":". Ocular symptoms and signs with preserved and preservative-free glaucoma medications.","volume":"17","author":"Jaenen","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"R5-6-20210204","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","article-title":"Prevalence of ocular surface disease in glaucoma patients.","volume":"17","author":"Leung","year":"2008","journal-title":"J Glaucoma"},{"key":"R6-6-20210204","first-page":"186","article-title":"Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe in French.","volume":"22","author":"Levrat","year":"1999","journal-title":"J Fr Ophtalmol"},{"key":"R7-6-20210204","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.","volume":"86","author":"Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R8-6-20210204","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00417-008-0881-9","article-title":"German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye.","volume":"246","author":"Erb","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-6-20210204","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007).","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R10-6-20210204","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1167\/iovs.05-1504","article-title":". Tear film osmolarity: determination of a referent for dry eye diagnosis.","volume":"47","author":"Tomlinson","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R11-6-20210204","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1167\/iovs.02-0581","article-title":". Apoptosis of ocular surface cells in experimentally induced dry eye.","volume":"44","author":"Yeh","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-6-20210204","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":". Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.","volume":"45","author":"Luo","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-6-20210204","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1542-0124(12)70028-9","article-title":"Tear osmolarity.","volume":"4","author":"Murube","year":"2006","journal-title":"Ocul Surf"},{"key":"R14-6-20210204","first-page":"3442","article-title":". Basal tear turnover and topical timolol in glaucoma patients and healthy controls by fluorophotometry.","volume":"33","author":"Kuppens","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-6-20210204","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1136\/bjo.84.11.1250","article-title":". Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5 timolol v 0. 12 unoprostone.","volume":"84","author":"Shimazaki","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R16-6-20210204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02391207","article-title":". Effects of timolol maleate on tear flow in human eyes.","volume":"213","author":"Bonomi","year":"1980","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"R17-6-20210204","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.ophtha.2010.03.064","article-title":". Tear cytokine profile in medicated glaucoma patients: effect of monocyte chemoattractant protein 1 on early posttrabeculectomy outcome.","volume":"117","author":"Chong","year":"2010","journal-title":"Ophthalmology"},{"key":"R18-6-20210204","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.2006.101485","article-title":". Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.","volume":"91","author":"Malvitte","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R19-6-20210204","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1167\/iovs.09-4596","article-title":". Tear osmolarity as a biomarker for dry eye disease severity.","volume":"51","author":"Suzuki","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-6-20210204","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1167\/iovs.10-5390","article-title":". An objective approach to dry eye disease severity.","volume":"51","author":"Sullivan","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-6-20210204","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":". Reliability and validity of the Ocular Surface Disease Index.","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R22-6-20210204","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests.","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"R23-6-20210204","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/112067210901900409","article-title":". Dry eye syndrome-related quality of life in glaucoma patients.","volume":"19","author":"Rossi","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"R24-6-20210204","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-1-75","article-title":". Vision related quality of life and topical glaucoma treatment side effects.","volume":"1","author":"Nordmann","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R25-6-20210204","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/02713683.2010.484557","article-title":"Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.","volume":"35","author":"Versura","year":"2010","journal-title":"Curr Eye Res"},{"key":"R26-6-20210204","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1001\/archopht.1994.01090230051020","article-title":". Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile.","volume":"112","author":"Broadway","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R27-6-20210204","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1542-0124(12)70187-8","article-title":"The association between symptoms of discomfort and signs in dry eye.","volume":"7","author":"Johnson","year":"2009","journal-title":"Ocul Surf"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-201209000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:49:14Z","timestamp":1618278554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201209000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31823f8cb6","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}